drugset / Trial / NCT00043212

Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.

NCT00043212 ↗

Phase 3 Withdrawn Northwest Biotherapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this clinical research study is to assess the safety and efficacy of an investigational therapy called DCVax(TM)-Prostate.

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped: “Redirection of company goals”

Drugs

EvaluationDrugModalityDoseRoute
Subject DCVax(TM)-Prostate Cell therapy — —

Indications